S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Will the Energy Sector Continue to Outshine the Market?
Buy This Stock for AI Tidal Wave (not NVDA) (Ad)
Borrowers are reassessing their budgets as student loan payments resume after pandemic pause
MarketBeat Week in Review – 9/25 - 9/29
Better Than Oil Stocks (Ad)
Cyprus hails Moody's two-notch credit rating upgrade bringing the country into investment grade
Almost all of Nagorno-Karabakh's people have left, Armenia's government says
Better Than Oil Stocks (Ad)
Powerball jackpot rises to $1.04 billion after another drawing without a big winner
Promoting tradition as well as beans, Ethiopian coffee shops find fans far from home
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Will the Energy Sector Continue to Outshine the Market?
Buy This Stock for AI Tidal Wave (not NVDA) (Ad)
Borrowers are reassessing their budgets as student loan payments resume after pandemic pause
MarketBeat Week in Review – 9/25 - 9/29
Better Than Oil Stocks (Ad)
Cyprus hails Moody's two-notch credit rating upgrade bringing the country into investment grade
Almost all of Nagorno-Karabakh's people have left, Armenia's government says
Better Than Oil Stocks (Ad)
Powerball jackpot rises to $1.04 billion after another drawing without a big winner
Promoting tradition as well as beans, Ethiopian coffee shops find fans far from home
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Will the Energy Sector Continue to Outshine the Market?
Buy This Stock for AI Tidal Wave (not NVDA) (Ad)
Borrowers are reassessing their budgets as student loan payments resume after pandemic pause
MarketBeat Week in Review – 9/25 - 9/29
Better Than Oil Stocks (Ad)
Cyprus hails Moody's two-notch credit rating upgrade bringing the country into investment grade
Almost all of Nagorno-Karabakh's people have left, Armenia's government says
Better Than Oil Stocks (Ad)
Powerball jackpot rises to $1.04 billion after another drawing without a big winner
Promoting tradition as well as beans, Ethiopian coffee shops find fans far from home
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Will the Energy Sector Continue to Outshine the Market?
Buy This Stock for AI Tidal Wave (not NVDA) (Ad)
Borrowers are reassessing their budgets as student loan payments resume after pandemic pause
MarketBeat Week in Review – 9/25 - 9/29
Better Than Oil Stocks (Ad)
Cyprus hails Moody's two-notch credit rating upgrade bringing the country into investment grade
Almost all of Nagorno-Karabakh's people have left, Armenia's government says
Better Than Oil Stocks (Ad)
Powerball jackpot rises to $1.04 billion after another drawing without a big winner
Promoting tradition as well as beans, Ethiopian coffee shops find fans far from home
NYSE:ENFN

Enfusion (ENFN) Stock Forecast, Price & News

$8.97
+0.11 (+1.24%)
(As of 09/29/2023 ET)
Compare
Today's Range
$8.91
$9.12
50-Day Range
$7.83
$10.90
52-Week Range
$7.37
$14.61
Volume
202,229 shs
Average Volume
432,050 shs
Market Capitalization
$1.11 billion
P/E Ratio
112.14
Dividend Yield
N/A
Price Target
$11.00

Enfusion MarketRank™ Forecast

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
22.6% Upside
$11.00 Price Target
Short Interest
Bearish
4.11% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
-0.12mentions of Enfusion in the last 14 days
Based on 2 Articles This Week
Insider Trading
Selling Shares
$10.84 M Sold Last Quarter
Proj. Earnings Growth
90.00%
From $0.10 to $0.19 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.16 out of 5 stars

Computer And Technology Sector

351st out of 605 stocks

Prepackaged Software Industry

105th out of 205 stocks


ENFN stock logo

About Enfusion (NYSE:ENFN) Stock

Enfusion, Inc. provides software-as-a-service solutions for investment management industry in the United States, Europe, the Middle East, Africa, and the Asia Pacific. The company provides portfolio management system, which generates a real-time investment book of record that consists of valuation and risk tools that allows users to analyze aggregated or decomposed portfolio data for chief investment officers (CIOs) and portfolio managers; and order and execution management system that enables portfolio managers, traders, compliance teams, and analysts to electronically communicate trade orders for a variety of asset classes, manage trade orders, and systemically enforce trading regulations and internal guidelines. It also offers accounting/general ledger system, a real-time accounting book of record for chief financial officers, chief operating officers, accountants, and operations teams; Enfusion analytics system, which enables CIOs, portfolio managers, traders, and analysts to analyze portfolios through time horizons and automate customized visualized reports for internal and external stakeholders; and technology-powered and managed services. The company was founded in 1997 and is headquartered in Chicago, Illinois.

ENFN Price History

ENFN Stock News Headlines

Is Enfusion, Inc. (NYSE:ENFN) Trading At A 30% Discount?
New Cash Law Will Be Disaster for Savers
New law has expert warning seniors and retirees to beware. There's a darker truth behind this financial bombshell...
Enfusion (NYSE: ENFN)
Enfusion Inc.
Laser breakthrough could send stock soaring 2,467%
Laser breakthrough could send stock soaring 2,476% Whenever the military develops a breakthrough technology, timely investors could see groundbreaking returns. General Dynamics returned 8,990%... Boeing soared 4,238%... L3Harris shot up 1,628%...
Enfusion Inc. Class A
Enfusion (ENFN) Receives a Buy from Stifel Nicolaus
J.P. Morgan Keeps Their Hold Rating on Enfusion (ENFN)
Enfusion (ENFN) Gets a Hold from Goldman Sachs
Why Enfusion (ENFN) Stock Is Exploding Higher
Enfusion: Multiple Catalysts
See More Headlines
Receive ENFN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Enfusion and its competitors with MarketBeat's FREE daily newsletter.

ENFN Company Calendar

Last Earnings
8/08/2023
Today
10/01/2023
Next Earnings (Estimated)
11/09/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Prepackaged software
Sub-Industry
N/A
Fax
N/A
Employees
1,006
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$11.00
High Stock Price Forecast
$14.00
Low Stock Price Forecast
$9.00
Forecasted Upside/Downside
+22.6%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
5 Analysts

Profitability

Net Income
$-7,650,000.00
Pretax Margin
6.35%

Debt

Sales & Book Value

Annual Sales
$163.36 million
Book Value
$0.91 per share

Miscellaneous

Free Float
75,069,000
Market Cap
$1.11 billion
Optionable
Not Optionable
Beta
0.88
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Key Executives

  • Mr. Oleg Movchan (Age 48)
    CEO & Director
    Comp: $876.34k
  • Mr. Bradley Herring (Age 52)
    Chief Financial Officer
    Comp: $267.05k
  • Ms. Bronwen Bastone (Age 50)
    Chief People Officer
    Comp: $566.25k
  • Mr. Stephen Malherbe
    Managing Partner
  • Mr. Michael Berry
    Chief Operating Officer
  • Mr. Daniel Groman (Age 34)
    Chief Technology Officer
  • Mr. Ignatius Tochukwu Njoku
    Head of Investor Relations
  • Matt Campobasso
    Gen. Counsel
  • Mr. Dan Jacobs
    Global Head of Sales
  • Caroline Ma
    Head of Corp. Devel.













ENFN Stock - Frequently Asked Questions

Should I buy or sell Enfusion stock right now?

5 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Enfusion in the last year. There are currently 1 sell rating, 3 hold ratings and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" ENFN shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in ENFN, but not buy additional shares or sell existing shares.
View ENFN analyst ratings
or view top-rated stocks.

What is Enfusion's stock price forecast for 2023?

5 brokers have issued 12-month price targets for Enfusion's stock. Their ENFN share price forecasts range from $9.00 to $14.00. On average, they anticipate the company's stock price to reach $11.00 in the next twelve months. This suggests a possible upside of 22.6% from the stock's current price.
View analysts price targets for ENFN
or view top-rated stocks among Wall Street analysts.

How have ENFN shares performed in 2023?

Enfusion's stock was trading at $9.67 at the beginning of 2023. Since then, ENFN stock has decreased by 7.2% and is now trading at $8.97.
View the best growth stocks for 2023 here
.

Are investors shorting Enfusion?

Enfusion saw a increase in short interest in the month of September. As of September 15th, there was short interest totaling 1,750,000 shares, an increase of 36.7% from the August 31st total of 1,280,000 shares. Based on an average trading volume of 421,100 shares, the short-interest ratio is currently 4.2 days. Approximately 4.1% of the company's shares are short sold.
View Enfusion's Short Interest
.

When is Enfusion's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, November 9th 2023.
View our ENFN earnings forecast
.

How were Enfusion's earnings last quarter?

Enfusion, Inc. (NYSE:ENFN) announced its quarterly earnings results on Tuesday, August, 8th. The company reported $0.02 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.02. The business had revenue of $42.72 million for the quarter, compared to analysts' expectations of $44.58 million. Enfusion had a trailing twelve-month return on equity of 8.10% and a net margin of 3.61%.

What guidance has Enfusion issued on next quarter's earnings?

Enfusion issued an update on its FY 2023 earnings guidance on Tuesday, August, 8th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $170.00 million-$175.00 million, compared to the consensus revenue estimate of $186.50 million.

When did Enfusion IPO?

(ENFN) raised $300 million in an IPO on Thursday, October 21st 2021. The company issued 18,750,000 shares at a price of $15.00-$17.00 per share.

What is Enfusion's stock symbol?

Enfusion trades on the New York Stock Exchange (NYSE) under the ticker symbol "ENFN."

How do I buy shares of Enfusion?

Shares of ENFN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Enfusion's stock price today?

One share of ENFN stock can currently be purchased for approximately $8.97.

How much money does Enfusion make?

Enfusion (NYSE:ENFN) has a market capitalization of $1.11 billion and generates $163.36 million in revenue each year. The company earns $-7,650,000.00 in net income (profit) each year or $0.08 on an earnings per share basis.

How many employees does Enfusion have?

The company employs 1,006 workers across the globe.

How can I contact Enfusion?

The official website for the company is www.enfusion.com. The company can be reached via phone at 312-253-9800 or via email at brian.murphy@icrinc.com.

This page (NYSE:ENFN) was last updated on 10/1/2023 by MarketBeat.com Staff

My Account -